The genetic defect-adenosine deaminase (ADA) deficiency may be cured permanently by
Enzyme replacement therapy
Periodic infusion of genetically engineered lymphocytes having functional ADA cDNA
Administering adenosine deaminase activators
Introducing bone marrow cells producing ADA into cells at early embryonic stages